Pharm'Up
The American Academy of Pediatrics (AAP) has issued its own 2025 child and adolescent immunization schedule, a...
A study published in Frontiers in Cellular and Infection Microbiology reveals how non-pharmaceutical interventions (NPIs) during the...
A new 52-week study has provided strong evidence that tocilizumab-anoh (Avtozma), a biosimilar of the reference drug...
A new study published in JAMA Pediatrics has uncovered why some children with asthma continue to suffer...
The FDA has granted approval to donidalorsen (Dawnzera; Ionis Pharmaceuticals Inc.), marking a significant advancement in the...
A large-scale, real-world study published in Blood Advances challenges the long-held assumption that regular immunoglobulin replacement therapy...
A new study in JAMA Network Open reveals a direct link between long-term obesity and accelerated biological...
In the evolving landscape of relapsing-remitting multiple sclerosis (RRMS) treatment, doctors often weigh aggressive therapeutic options based...
Antibody-drug conjugates (ADCs) merge monoclonal antibodies with potent cytotoxic agents to precisely target cancer cells, minimizing damage...
A recent multicenter study published in Cell Reports Medicine highlights a promising therapeutic strategy for small cell...
